Surgical denervation of ocular sympathetic afferents decreases local transforming growth factor-beta and abolishes immune privilege.
Mounting evidence points to a role for the sympathetic nervous system in suppressing inflammation. This role might be of specific relevance for immune privilege in the eye, where, sporadically, patients with denervated sympathetic fibers develop chronic inflammation. The present study used mice to investigate whether the robust innervation of intraocular structures by the sympathetic system plays a role in maintaining ocular immune privilege. We first performed surgical removal of the superior cervical ganglion, which supplies sympathetic fibers to the eye, and studied the immune response generated against soluble antigens or allogeneic tumor cells injected into the ocular anterior chamber under these conditions. Our results show that in the absence of functional sympathetic fibers, the eye loses its ability to prevent either the immune rejection of intraocular allogeneic tumor cells or the suppression of delayed type hypersensitivity responses against soluble antigens injected in the anterior chamber. This loss of immune privilege is accompanied by a decrease in the concentration of transforming growth factor-beta in the aqueous humor. These results suggest that immune privilege is lost in the absence of a functional sympathetic innervation of the eye, allowing intraocular immune responses to become exaggerated. We conclude that ocular sympathetic nerves are critical for the generation and maintenance of immune privilege in the eye through the facilitation of local transforming growth factor-beta production.
Vega
Jose L
JL
Schepens Eye Research Institute, 20 Staniford St., Boston, MA 02114, USA.
Keino
Hiroshi
H
Masli
Sharmila
S
D000818:Animals; D000867:Anterior Chamber / Q000276:immunology; D000941:Antigens / Q000276:immunology; D001082:Aqueous Humor / Q000276:immunology; D005123:Eye / Q000276:immunology / Q000294:innervation*; D015171:Ganglionectomy; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007109:Immunity / Q000502:physiology*; D051379:Mice; D008807:Mice, Inbred BALB C; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000276:immunology; D015213:Neuroimmunomodulation; D017783:Superior Cervical Ganglion / Q000502:physiology*; D016212:Transforming Growth Factor beta / Q000276:immunology*
D000941:Antigens; D016212:Transforming Growth Factor beta
Neuroscience. 2001;107(4):593-602
11720783
J Leukoc Biol. 2006 Jun;79(6):1093-104
16531560
J Immunol. 2002 Nov 1;169(9):5028-35
12391218
J Neuroimmunol. 1995 Aug;61(1):61-70
7560013
J Neurol Sci. 2007 Jan 15;252(1):29-35
17129587
Br J Ophthalmol. 1994 Dec;78(12):949
7819183
Invest Ophthalmol Vis Sci. 1994 Sep;35(10):3702-10
7522227
Exp Neurol. 2007 Sep;207(1):75-84
17597612
J Neuropathol Exp Neurol. 2003 Aug;62(8):848-54
14503640
J Neurosurg. 1991 Nov;75(5):766-73
1833515
Am J Physiol. 1995 Apr;268(4 Pt 1):C910-7
7733239
J Allergy Clin Immunol. 2000 Jan;105(1 Pt 1):91-8
10629458
J Neuroimmunol. 2004 Aug;153(1-2):40-9
15265662
Neuroscience. 2009 Feb 6;158(3):1184-93
18722511
Ann Neurol. 1980 Nov;8(5):520-5
6254440
J Immunol. 1999 Sep 1;163(5):2492-9
10452985
Eur J Immunol. 1992 Jan;22(1):165-73
1530916
J Fr Ophtalmol. 1990;13(11-12):557-61
2081848
Brain Behav Immun. 2000 Dec;14(4):239-55
11120594
Br J Pharmacol. 2001 Nov;134(5):977-84
11682445
J Immunol. 2001 Jan 1;166(1):232-40
11123297
Am J Ophthalmol. 1965 May;59:927-8
14288941
Gut. 2004 Mar;53(3):438-45
14960531
J Neurosurg. 1992 Nov;77(5):694-9
1403109
Invest Ophthalmol Vis Sci. 1996 Feb;37(2):413-24
8603847
Am J Ophthalmol. 2000 May;129(5):672-3
10844066
J Immunol. 2004 Feb 1;172(3):1567-74
14734736
Br J Ophthalmol. 2006 Jul;90(7):812-3
16782945
Clin Exp Allergy. 2008 Jul;38(7):1160-7
18691294
Invest Ophthalmol Vis Sci. 2000 Mar;41(3):811-21
10711698
J Exp Med. 1980 Oct 1;152(4):1121-5
6775039
Histol Histopathol. 2001 Oct;16(4):1135-41
11642733
Trends Pharmacol Sci. 2004 Dec;25(12):640-6
15530642
Hypertension. 2004 Oct;44(4):392-3
15326090
J Leukoc Biol. 2003 Aug;74(2):179-85
12885934
Mol Vis. 2008 Mar 26;14:615-24
18385797
Exp Eye Res. 1976 Mar;22(3):259-65
1269546
Acta Physiol Pharmacol Latinoam. 1987;37(3):305-19
3332531
Arch Ophtalmol Rev Gen Ophtalmol. 1953;13(5):512-3
13125747
Hypertension. 2004 Oct;44(4):410-8
15326086
Pharmacol Rev. 1974 Sep;26(3):199-288
4376244
Invest Ophthalmol Vis Sci. 1989 Feb;30(2):323-9
2492486
Anesth Analg. 2004 Nov;99(5):1508-1515
15502056
Nat Med. 1998 Jul;4(7):808-13
9662372
Am J Ophthalmol. 2008 Aug;146(2):292-7
18547534
Hum Immunol. 2002 Jun;63(6):435-43
12039518
Br J Ophthalmol. 1987 Nov;71(11):844-9
3689736
Cancer Immunol Immunother. 2000 Sep;49(7):361-8
10999462
Invest Ophthalmol Vis Sci. 1991 Jul;32(8):2201-11
2071334